Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Buy
51
JANX Quote, Financials, Valuation and Earnings
Last price:
$28.82
Seasonality move
:
-1.19%
Day range:
$26.02 - $28.90
52-week range:
$22.52 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
118.62x
P/B ratio:
1.66x
Volume:
2M
Avg. volume:
1M
1-year change:
-42.4%
Market cap:
$1.7B
Revenue:
$10.6M
EPS (TTM):
-$1.28
Earnings Data
Next earnings date for JANX
May 08
2025
Most recent earnings per share
-$0.36
Beat by $0.09
(Dec 31/2024)
Consensus Estimate
-$0.45
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JANX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $660K | -- | -- | -$0.46 | -- |
| 05/08/2025 | Q1 | $650K | -- | -- | -$0.39 | -- |
| 12/31/2024 | Q4 | $1.3M | -- | -$0.36 | -$0.45 | $0.09 |
| 11/06/2024 | Q3 | $1.6M | $439K | -$0.51 | -$0.36 | -$0.15 |
| 08/07/2024 | Q2 | $863.1K | $8.9M | -$0.11 | -$0.29 | $0.18 |
| 05/08/2024 | Q1 | $1M | $1.3M | -$0.30 | -$0.33 | $0.03 |
| 03/08/2024 | Q4 | $739.3K | $2.5M | -$0.24 | -$0.39 | $0.15 |
| 11/07/2023 | Q3 | -- | -- | -$0.25 | -$0.43 | $0.18 |
| 08/08/2023 | Q2 | -- | -- | -$0.42 | -$0.51 | $0.09 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.47 | $0.05 |
| 03/10/2023 | Q4 | -- | -- | -$0.39 | -$0.50 | $0.11 |
| 11/10/2022 | Q3 | -- | -- | -$0.40 | -$0.53 | $0.13 |
| 08/09/2022 | Q2 | -- | -- | -$0.41 | -$0.39 | -$0.02 |
| 05/10/2022 | Q1 | -- | -- | -$0.32 | -- | -- |
| 03/18/2022 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.26 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$0.62 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.20 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.11 | -- | -- |
Janux Therapeutics Earnings Questions
-
How Much did Janux Therapeutics Generate in Revenue Last Quarter?
Janux Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Janux Therapeutics Beat Earnings Last Quarter?
Janux Therapeutics announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.45 per share.
-
Is Janux Therapeutics Profitable?
Janux Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Janux Therapeutics EPS Next Year?
Janux Therapeutics's earnings are forecast to decrease from -$1.28 per share to -$2.08 per share next year representing a decrease of -59.72%.
-
When is Janux Therapeutics's Earnings Date?
Janux Therapeutics's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
